z-logo
open-access-imgOpen Access
MANAGEMENT OF GESTASIONAL DIABETES MELLITUS IN A BETA MAJOR THALASSEMIA PATIENT
Author(s) -
Troy Fonda,
Hermiovida
Publication year - 2021
Publication title -
current internal medicine research and practice surabaya journal
Language(s) - English
Resource type - Journals
ISSN - 2721-544X
DOI - 10.20473/cimrj.v2i2.26255
Subject(s) - gestational diabetes , medicine , thalassemia , pregnancy , diabetes mellitus , beta thalassemia , obstetrics , fetus , incidence (geometry) , pediatrics , gestation , endocrinology , biology , genetics , physics , optics
Gestational diabetes mellitus (GDM) is a hyperglycemic condition that is first discovered during pregnancy. GDM is a high-risk condition during pregnancy, for both mother and fetus. GDM affects about 1–14% of pregnancies. In the last 20 years, the incidence of gestational diabetes has been increasing. High iron load and disorders of iron metabolism have been associated with glucose metabolism. The beta thalassemias are a group of hereditary hemoglobinopathies. Treatment for beta thalassemias patients is transfusion, but intensive transfusion can aggravate iron overload in patients. In this study, a case of GDM in a pregnant woman with beta-thalassemia was reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom